Rosetta Genomics (ROSG) Reports Favorable Outcome in German Patent Suit
Tweet Send to a Friend
Rosetta Genomics (Nasdaq: ROSG) announces that the European Patent Office (EPO) has upheld the validity of the Company’s European Patent ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
